{
"id":"mk19_a_id_s13",
"subspecialtyId":"id",
"title":"Bioterrorism",
"jsonContent":{
"type":"section",
"id":"mk19_a_id_s13",
"title":{
"__html":"Bioterrorism"
},
"titleNode":{
"type":"section-title",
"hlId":"ad7c7c",
"children":[
"Bioterrorism"
]
},
"children":[
{
"type":"section",
"id":"mk19_a_id_s13_1",
"title":{
"__html":"Introduction"
},
"titleNode":{
"type":"section-title",
"hlId":"0b7979",
"children":[
"Introduction"
]
},
"children":[
{
"type":"p",
"hlId":"2e2bef",
"children":[
"Unusually severe illness, rapid increase in disease incidence, atypical clinical presentation, and uncommon geographic, temporal, or demographic clustering of disease outbreaks suggest a bioterrorism attack. Bioterrorism agents are classified ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_id_t37",
"wrapId":"1",
"children":[
"Table 37"
]
}
]
},
")"
]
},
" according to ease of dissemination, mortality rate, potential for public panic and social disruption, and need for special action for public health preparedness."
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_a_id_t37"
]
}
]
},
{
"type":"section",
"id":"mk19_a_id_s13_2",
"title":{
"__html":"Anthrax"
},
"titleNode":{
"type":"section-title",
"hlId":"06efe1",
"children":[
"Anthrax"
]
},
"children":[
{
"type":"p",
"hlId":"5a5805",
"children":[
"Anthrax infection is caused by ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Bacillus anthracis"
]
},
" spores ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_a_id_f27",
"wrapId":"2",
"children":[
"Figure 27"
]
}
]
}
]
},
" panel A and ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_a_id_f27",
"wrapId":"2",
"children":[
"Figure 27"
]
}
]
},
" panel B). Spores may be spread by aerosolization or in the mail, with infection following inhalation; any case of inhalation anthrax must be considered potential bioterrorism. Infection may also occur by cutaneous contact, with a characteristic black eschar forming ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_a_id_f27",
"wrapId":"2",
"children":[
"Figure 27"
]
}
]
}
]
},
" panel C), or by ingestion. Person-to-person transmission does not occur."
]
},
{
"type":"inline-wrap",
"wrapId":"2",
"contentIds":[
"mk19_a_id_f27"
]
},
{
"type":"p",
"hlId":"7eeecb",
"children":[
"Clinical features are described in ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_id_t38",
"wrapId":"3",
"children":[
"Table 38"
]
}
]
},
". Meningitis occurs in up to 50% of persons. Rapid clinical deterioration leads to shock and death. Radiographic imaging reveals a widened mediastinum ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_a_id_f27",
"wrapId":"3",
"children":[
"Figure 27"
]
}
]
}
]
},
" panel D). Diagnosis is made by culture or polymerase chain reaction (PCR) of blood, tissues, or fluid samples."
]
},
{
"type":"inline-wrap",
"wrapId":"3",
"contentIds":[
"mk19_a_id_t38",
"mk19_a_id_f27"
]
},
{
"type":"p",
"hlId":"03a5c0",
"children":[
"Treatment is outlined in ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_id_t38",
"wrapId":"4",
"children":[
"Table 38"
]
}
]
},
". Postexposure prophylaxis consists of a fluoroquinolone or doxycycline in conjunction with vaccination or monoclonal antibodies when alternative preventive therapies cannot be used or are unavailable."
]
},
{
"type":"inline-wrap",
"wrapId":"4",
"contentIds":[
"mk19_a_id_t38"
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"96f1ba",
"children":[
"Any case of inhalational anthrax should be considered potential bioterrorism."
]
},
{
"type":"keypoint",
"hlId":"3acc58",
"children":[
"Patients with inhalational anthrax infection present with malaise, myalgia, fever, cough, dyspnea, and substernal chest discomfort; radiographic imaging reveals a widened mediastinum."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_id_s13_3",
"title":{
"__html":"Smallpox (Variola)"
},
"titleNode":{
"type":"section-title",
"hlId":"3e144d",
"children":[
"Smallpox (Variola)"
]
},
"children":[
{
"type":"p",
"hlId":"c7dfba",
"children":[
"Routine smallpox vaccination ceased in 1980, after the World Health Organization declared the disease eradicated, leaving much of the world's population without immunity. Following inhalation, multiplication in regional lymph nodes results in viremia."
]
},
{
"type":"p",
"hlId":"f252e6",
"children":[
"Secondary viremia occurs 1 week later, accompanied by fever, systemic symptoms, and rash, beginning with lesions on the oral mucosa and face and then the arms, legs, hands and feet, and to a lesser extent the trunk ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_a_id_f28",
"wrapId":"5",
"children":[
"Figure 28"
]
}
]
},
")"
]
},
". Patients remain contagious until all scabs and crusts are shed. Mortality ranges from 15% to 50%."
]
},
{
"type":"inline-wrap",
"wrapId":"5",
"contentIds":[
"mk19_a_id_f28"
]
},
{
"type":"p",
"hlId":"d22523",
"children":[
"Treatment is listed in ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_id_t38",
"wrapId":"6",
"children":[
"Table 38"
]
}
]
},
". Vaccination should be provided to close contacts. Intravenous vaccinia immune globulin is indicated in certain vaccinia-related complications or when vaccination is contraindicated."
]
},
{
"type":"inline-wrap",
"wrapId":"6",
"contentIds":[
"mk19_a_id_t38"
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"a07910",
"children":[
"Smallpox viremia results in fever and systemic symptoms, followed by lesions on the oral mucosa, then the face, and then the arms, legs, hands and feet, and to a lesser extent the trunk."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_id_s13_4",
"title":{
"__html":"Plague"
},
"titleNode":{
"type":"section-title",
"hlId":"19b8bf",
"children":[
"Plague"
]
},
"children":[
{
"type":"p",
"hlId":"e9bfd0",
"children":[
"Primary pneumonic plague occurs after ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Yersinia pestis"
]
},
" ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_a_id_f29",
"wrapId":"7",
"children":[
"Figure 29"
]
}
]
},
")"
]
},
" exposure through infectious aerosols and person-to-person transmission through respiratory droplets, which are likely scenarios for bioterrorism. Patients with suspected pneumonic plague require droplet precautions. Chest radiographs are nonspecific. Gram stain and cultures of sputum and blood (performed using the highest level biosafety procedures) are often diagnostic."
]
},
{
"type":"inline-wrap",
"wrapId":"7",
"contentIds":[
"mk19_a_id_f29"
]
},
{
"type":"p",
"hlId":"b9b22b",
"children":[
"Clinical features and treatment are outlined in ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_id_t38",
"wrapId":"8",
"children":[
"Table 38"
]
}
]
},
". Untreated, pneumonic plague is uniformly fatal. Asymptomatic persons exposed to aerosolized ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Y. pestis"
]
},
" and close contacts of infected patients within the previous 7 days warrant postexposure prophylaxis. A live attenuated vaccine with protection from respiratory challenge is under investigation."
]
},
{
"type":"inline-wrap",
"wrapId":"8",
"contentIds":[
"mk19_a_id_t38"
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"2982da",
"children":[
"Primary pneumonic plague occurs after ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Yersinia pestis"
]
},
" exposure through infectious aerosols and person-to-person transmission through respiratory droplets, which are likely scenarios for bioterrorism."
]
},
{
"type":"keypoint",
"hlId":"8502d2",
"children":[
"Asymptomatic persons exposed to aerosolized ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Yersinia pestis"
]
},
" and close contacts of infected patients within the previous 7 days warrant postexposure prophylaxis with ciprofloxacin, levofloxacin, moxifloxacin, or doxycycline."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_id_s13_5",
"title":{
"__html":"Botulism"
},
"titleNode":{
"type":"section-title",
"hlId":"5056ce",
"children":[
"Botulism"
]
},
"children":[
{
"type":"p",
"hlId":"71a095",
"children":[
"Botulism may spread in a bioterrorism attack through inhalation or ingestion of botulinum neurotoxin after deliberate aerosol release or purposeful food contamination. Clinical features are described in ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_id_t38",
"wrapId":"9",
"children":[
"Table 38"
]
}
]
},
". Patients remain afebrile and mental status remains normal, but nausea, abdominal pain, and dry mouth often accompany the paralysis. Autonomic dysfunction may also occur."
]
},
{
"type":"inline-wrap",
"wrapId":"9",
"contentIds":[
"mk19_a_id_t38"
]
},
{
"type":"p",
"hlId":"a681f9",
"children":[
"Diagnosis depends on identifying the toxin from serum, vomitus, stool, gastric contents, or foods. Treatment is supportive (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_id_t38",
"wrapId":"10",
"children":[
"Table 38"
]
}
]
},
")"
]
},
". Heptavalent antitoxin should be obtained from the CDC and administered promptly but will not reverse existent paralysis. Antibiotics are not useful."
]
},
{
"type":"inline-wrap",
"wrapId":"10",
"contentIds":[
"mk19_a_id_t38"
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"987fd7",
"children":[
"Botulism treatment includes supportive care and early administration of antitoxin, although this will not reverse existent paralysis."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_id_s13_6",
"title":{
"__html":"Tularemia"
},
"titleNode":{
"type":"section-title",
"hlId":"815163",
"children":[
"Tularemia"
]
},
"children":[
{
"type":"p",
"hlId":"926443",
"children":[
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Francisella tularensis"
]
},
" is transmitted by vectors, direct animal contact, and inhalation; person-to-person spread does not occur. Chest radiographs demonstrate infiltrates, hilar lymphadenopathy, and pleural effusions."
]
},
{
"type":"p",
"hlId":"b16de6",
"children":[
"Rapid diagnosis relies on a good history and serologic, immunohistochemical, and PCR testing; culture of tissues and fluids is low yield and potentially dangerous to laboratory personnel. Treatment is noted in ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_id_t38",
"wrapId":"11",
"children":[
"Table 38"
]
}
]
},
". Death occurs in less than 4% of treated patients, but mortality rates reach 30% in untreated pneumonic or typhoidal tularemia. No vaccine is available."
]
},
{
"type":"inline-wrap",
"wrapId":"11",
"contentIds":[
"mk19_a_id_t38"
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"af5f8f",
"children":[
"Patients with tularemia experience abrupt onset of fever and respiratory symptoms, and chest radiographs demonstrate infiltrates, hilar lymphadenopathy, and pleural effusions."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_id_s13_7",
"title":{
"__html":"Viral Hemorrhagic Fever"
},
"titleNode":{
"type":"section-title",
"hlId":"29bc7c",
"children":[
"Viral Hemorrhagic Fever"
]
},
"children":[
{
"type":"p",
"hlId":"9f8cf0",
"children":[
"The Ebola and Marburg hemorrhagic viruses are the most likely to be used as biologic weapons. In endemic areas, they are spread by vectors, contact with bodily fluids, or fomites. Aerosolization is a likely mode of terrorist dissemination. Symptoms appear 2 to 21 days after exposure (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_id_t38",
"wrapId":"12",
"children":[
"Table 38"
]
}
]
},
")"
]
},
". Mortality rates can reach 90%."
]
},
{
"type":"inline-wrap",
"wrapId":"12",
"contentIds":[
"mk19_a_id_t38"
]
},
{
"type":"p",
"hlId":"08c714",
"children":[
"Depending on the stage of infection, diagnosis may be confirmed by antigen and antibody assays and PCR. Exposed persons are monitored during the incubation period, with prompt isolation if symptoms develop. Treatment is supportive (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_id_t38",
"wrapId":"13",
"children":[
"Table 38"
]
}
]
},
")"
]
},
". Antiviral medications are under development. An effective, preventative vaccine is now available."
]
},
{
"type":"inline-wrap",
"wrapId":"13",
"contentIds":[
"mk19_a_id_t38"
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"27a79d",
"children":[
"Symptoms of viral hemorrhagic fever include fever, headache, myalgia, abdominal pain, diarrhea, and unexplained bleeding and bruising appearing 2 to 21 days after exposure; disease progression results in hemorrhagic diathesis, shock, and multiorgan failure."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_id_s13_8",
"bibliography":true,
"title":{
"__html":"Bibliography"
},
"titleNode":{
"type":"section-title",
"hlId":"a7cc81",
"children":[
"Bibliography"
]
},
"children":[
{
"type":"references",
"children":[
{
"type":"reference",
"children":[
"Breman JG, Henderson DA. Diagnosis and management of smallpox. N Engl J Med. 2002;346:1300-8. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/11923491",
"target":"_blank"
},
"children":[
"PMID: 11923491"
]
},
" doi:10.1056/NEJMra020025"
]
},
{
"type":"reference",
"children":[
"Green MS, LeDuc J, Cohen D, et al. Confronting the threat of bioterrorism: realities, challenges, and defensive strategies. Lancet Infect Dis. 2019;19:e2-e13. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30340981",
"target":"_blank"
},
"children":[
"PMID: 30340981"
]
},
" doi:10.1016/S1473-3099(18)30298-6"
]
},
{
"type":"reference",
"children":[
"Hendricks KA, Wright ME, Shadomy SV, Bradley JS, Morrow MG, Pavia AT, et al; Workgroup on Anthrax Clinical Guidelines. Centers for Disease Control and Prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis. 2014;20. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/24447897",
"target":"_blank"
},
"children":[
"PMID: 24447897"
]
},
" doi:10.3201/eid2002.130687"
]
},
{
"type":"reference",
"children":[
"Malvy D, McElroy AK, de Clerck H, et al. Ebola virus disease. Lancet. 2019;393:936-948. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30777297",
"target":"_blank"
},
"children":[
"PMID: 30777297"
]
},
" doi:10.1016/S0140-6736(18)33132-5"
]
},
{
"type":"reference",
"children":[
"Narayanan N, Lacy CR, Cruz JE, et al. Disaster preparedness: Biological threats and treatment options. Pharmacotherapy. 2018;38:217-234. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/29236288",
"target":"_blank"
},
"children":[
"PMID: 29236288"
]
},
" doi:10.1002/phar.2068"
]
},
{
"type":"reference",
"children":[
"Nelson CA, Meaney-Delman D, Fleck-Derderian S, et al. Antimicrobial treatment and prophylaxis of plague: Recommendations for naturally acquired infections and bioterrorism response. MMWR Recomm Rep. 2021;70:1-27. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/34264565",
"target":"_blank"
},
"children":[
"PMID: 34264565"
]
},
" doi:10.15585/mmwr.rr7003a1"
]
},
{
"type":"reference",
"children":[
"Rao AK, Lin NH, Jackson KA, et al. Clinical characteristics and ancillary test results among patients with botulism-United States, 2002-2015. Clin Infect Dis. 2017;66:S4-S10. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/29293936",
"target":"_blank"
},
"children":[
"PMID: 29293936"
]
},
" doi:10.1093/cid/cix935"
]
},
{
"type":"reference",
"children":[
"Rao AK, Sobel J, Chatham-Stephens K, Luquez C. Clinical guidelines for diagnosis and treatment of botulism, 2021. MMWR Recomm Rep. 2021;70:1-30. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/33956777",
"target":"_blank"
},
"children":[
"PMID: 33956777"
]
},
" doi:10.15585/mmwr.rr7002a1"
]
},
{
"type":"reference",
"children":[
"Thomas LD, Schaffner W. Tularemia pneumonia. Infect Dis Clin North Am. 2010;24:43-55. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/20171544",
"target":"_blank"
},
"children":[
"PMID: 20171544"
]
},
" doi:10.1016/j.idc.2009.10.012"
]
},
{
"type":"reference",
"children":[
"Yang R. Plague: recognition, treatment, and prevention. J Clin Microbiol. 2018;56. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/29070654",
"target":"_blank"
},
"children":[
"PMID: 29070654"
]
},
" doi:10.1128/JCM.01519-17"
]
}
]
}
]
}
]
},
"tablesContent":{
"mk19_a_id_t37":{
"id":"mk19_a_id_t37",
"number":37,
"bookId":"id",
"title":{
"__html":"Potential Agents of Bioterrorism"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"b78236",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 37. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_id_t37"
}
]
},
"Potential Agents of Bioterrorism"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"71bcb4",
"class":"col hd l",
"children":[
"Class A",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"85572b",
"class":"col hd l",
"children":[
"Class B",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3826f8",
"class":"col hd l",
"children":[
"Class C",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"c"
]
}
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"06efe1",
"class":"cell txt l",
"children":[
"Anthrax"
]
},
" ",
{
"type":"p",
"hlId":"5056ce",
"class":"cell txt l",
"children":[
"Botulism"
]
},
" ",
{
"type":"p",
"hlId":"19b8bf",
"class":"cell txt l",
"children":[
"Plague"
]
},
" ",
{
"type":"p",
"hlId":"79c5e6",
"class":"cell txt l",
"children":[
"Smallpox"
]
},
" ",
{
"type":"p",
"hlId":"815163",
"class":"cell txt l",
"children":[
"Tularemia"
]
},
" ",
{
"type":"p",
"hlId":"b18e6d",
"class":"cell txt l",
"children":[
"Viral hemorrhagic fever"
]
},
" ",
{
"type":"p",
"hlId":"013ba1",
"class":"cell txt li",
"children":[
"Filoviruses (Ebola, Marburg)"
]
},
" ",
{
"type":"p",
"hlId":"1f0924",
"class":"cell txt li",
"children":[
"Arenaviruses (Lassa, Machupo)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f45075",
"class":"cell txt l",
"children":[
"Q fever"
]
},
" ",
{
"type":"p",
"hlId":"69652a",
"class":"cell txt l",
"children":[
"Brucellosis"
]
},
" ",
{
"type":"p",
"hlId":"bfd912",
"class":"cell txt l",
"children":[
"Glanders"
]
},
" ",
{
"type":"p",
"hlId":"d2ac92",
"class":"cell txt l",
"children":[
"Melioidosis"
]
},
" ",
{
"type":"p",
"hlId":"378c4f",
"class":"cell txt l",
"children":[
"Viral encephalitis"
]
},
" ",
{
"type":"p",
"hlId":"8cf031",
"class":"cell txt l",
"children":[
"Typhus fever"
]
},
" ",
{
"type":"p",
"hlId":"db06b3",
"class":"cell txt l",
"children":[
"Ricin toxin"
]
},
" ",
{
"type":"p",
"hlId":"58d7c9",
"class":"cell txt l",
"children":[
"Staphylococcal enterotoxin B"
]
},
" ",
{
"type":"p",
"hlId":"c7a017",
"class":"cell txt l",
"children":[
"Psittacosis"
]
},
" ",
{
"type":"p",
"hlId":"7f61cb",
"class":"cell txt l",
"children":[
"Foodborne illness"
]
},
" ",
{
"type":"p",
"hlId":"2a2153",
"class":"cell txt li",
"children":[
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Salmonella"
]
},
", ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Escherichia coli"
]
},
" O157:H7, ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Shigella"
]
}
]
},
" ",
{
"type":"p",
"hlId":"408f12",
"class":"cell txt l",
"children":[
"Waterborne illness"
]
},
" ",
{
"type":"p",
"hlId":"76dc4f",
"class":"cell txt li",
"children":[
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Cryptosporidium parvum"
]
},
", ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Vibrio cholerae"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fd41fb",
"class":"cell txt l",
"children":[
"Emerging infectious diseases"
]
},
" ",
{
"type":"p",
"hlId":"94c86f",
"class":"cell txt l",
"children":[
"Nipah virus"
]
},
" ",
{
"type":"p",
"hlId":"e9cb13",
"class":"cell txt l",
"children":[
"Hantavirus"
]
},
" ",
{
"type":"p",
"hlId":"0ed6e9",
"class":"cell txt l",
"children":[
"Novel influenza virus"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Greatest potential for use in an attack, easy dissemination, high mortality, and profound public health implications."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
"Less easily spread, fewer illnesses and deaths, fewer public health preparation measures required."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"c"
]
},
"Potential to be engineered for future mass dissemination and significant mortality."
]
]
},
"mk19_a_id_t38":{
"id":"mk19_a_id_t38",
"number":38,
"bookId":"id",
"title":{
"__html":"Class A Bioterrorism Agents"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"e40f82",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 38. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_id_t38"
}
]
},
"Class A Bioterrorism Agents"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"23eba1",
"class":"col hd l",
"children":[
"Disease—Agent"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"244a32",
"class":"col hd l",
"children":[
"Incubation Period"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7962dd",
"class":"col hd l",
"children":[
"Clinical Features"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"85e35a",
"class":"col hd l",
"children":[
"Preferred Treatment"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"264e21",
"class":"col hd l",
"children":[
"Prophylaxis"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"491acb",
"class":"cell txt l",
"children":[
"Anthrax—",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Bacillus anthracis"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cecb7f",
"class":"cell txt l",
"children":[
"1-60 days"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"506f3c",
"class":"cell txt l",
"children":[
"Inhalational: malaise, fever, myalgia, cough, dyspnea, substernal chest discomfort, respiratory distress"
]
},
" ",
{
"type":"p",
"hlId":"1fb669",
"class":"cell txt l",
"children":[
"Cutaneous: necrotic eschar"
]
},
" ",
{
"type":"p",
"hlId":"384e7e",
"class":"cell txt l",
"children":[
"Gastrointestinal: distention, peritonitis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4ed01c",
"class":"cell txt l",
"children":[
"Ciprofloxacin, levofloxacin, moxifloxacin, or doxycycline plus one or two additional agents",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
" for 60 days"
]
},
" ",
{
"type":"p",
"hlId":"c9edba",
"class":"cell txt l",
"children":[
"Consider raxibacumab, obiltoxaximab, or intravenous anthrax immune globulin",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"67ff38",
"class":"cell txt l",
"children":[
"Ciprofloxacin, levofloxacin, moxifloxacin, or doxycycline, along with vaccination",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"c"
]
}
]
},
" ",
{
"type":"p",
"hlId":"00de04",
"class":"cell txt l",
"children":[
"Amoxicillin if penicillin-sensitive strain",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"d"
]
}
]
},
" ",
{
"type":"p",
"hlId":"72a36c",
"class":"cell txt l",
"children":[
"Raxibacumab or obiltoxaximab",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"e"
]
}
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b09b81",
"class":"cell txt l",
"children":[
"Smallpox virus—variola virus"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bdb2a6",
"class":"cell txt l",
"children":[
"7-17 days"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a2cff1",
"class":"cell txt l",
"children":[
"Fever followed by pustular cutaneous rash (face, followed by upper extremities, lower extremities, and trunk); lesions evolve synchronously (same stage of maturation on any one area of the body) from macules to papules to vesicles to pustules before eventually crusting"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"23c3ee",
"class":"cell txt l",
"children":[
"Tecovirimat (approved in the event of a potential outbreak)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"131221",
"class":"cell txt l",
"children":[
"Vaccine if exposure occurred in the previous 7 days"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"87393c",
"class":"cell txt l",
"children":[
"Plague",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"—Yersinia pestis"
]
},
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"f"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7799c7",
"class":"cell txt l",
"children":[
"1-6 days"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0e8b87",
"class":"cell txt l",
"children":[
"Fulminant pneumonia and sepsis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3136a3",
"class":"cell txt l",
"children":[
"Ciprofloxacin, levofloxacin, moxifloxacin, gentamicin, or streptomycin for 10-14 days "
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"dcb702",
"class":"cell txt l",
"children":[
"Ciprofloxacin, levofloxacin, moxifloxacin, or doxycycline for 7 days"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c7f38e",
"class":"cell txt l",
"children":[
"Bubonic or pharyngeal plague"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"168a0c",
"class":"cell txt l",
"children":[
"Ciprofloxacin, levofloxacin, moxifloxacin, doxycycline, gentamicin, or streptomycin for 10-14 days "
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"593494",
"class":"cell txt l",
"children":[
"Botulism—",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Clostridium botulinum"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7df6f0",
"class":"cell txt l",
"children":[
"2 hours to 8 days"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3e1571",
"class":"cell txt l",
"children":[
"Cranial nerve palsies and symmetric descending flaccid paralysis with prominent bulbar signs (the “4 Ds” of diplopia, dysarthria, dysphonia, and dysphagia), which may progress to respiratory failure"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6a26e0",
"class":"cell txt l",
"children":[
"Antitoxin (HBAT)",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"g"
]
},
" and supportive care"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"615620",
"class":"cell txt l",
"children":[
"Antibotulinum antitoxin (equine serum heptavalent botulism toxin)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3be1a2",
"class":"cell txt l",
"children":[
"Tularemia—",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Francisella tularensis"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4c3456",
"class":"cell txt l",
"children":[
"3-5 days"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4a2b20",
"class":"cell txt l",
"children":[
"Abrupt onset fever, respiratory distress, and sepsis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7c4bd4",
"class":"cell txt l",
"children":[
"Streptomycin or gentamicin (severe disease) for 7 to 14 days"
]
},
" ",
{
"type":"p",
"hlId":"ccdae7",
"class":"cell txt l",
"children":[
"Chloramphenicol",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"h"
]
}
]
},
" ",
{
"type":"p",
"hlId":"022f7d",
"class":"cell txt l",
"children":[
"Doxycycline or ciprofloxacin (nonsevere disease) for 14 days"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"854f3e",
"class":"cell txt l",
"children":[
"Doxycycline or ciprofloxacin for 14 days"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b4f96a",
"class":"cell txt l",
"children":[
"Viral hemorrhagic fevers—Ebola and Marburg viruses"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"47c148",
"class":"cell txt l",
"children":[
"Variable"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e23f37",
"class":"cell txt l",
"children":[
"Maculopapular rash, fever, headache, myalgia, abdominal pain, diarrhea, unexplained bleeding and bruising; progression leads to shock, hemorrhage, and multiorgan failure"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"64f7f1",
"class":"cell txt l",
"children":[
"Supportive care"
]
},
" ",
{
"type":"p",
"hlId":"2fd9f9",
"class":"cell txt l",
"children":[
"Experimental antiviral medications"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"28ec9c",
"class":"cell txt l",
"children":[
"Vaccine (strictly for Zaire ebolavirus)"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Either penicillin, ampicillin, imipenem, meropenem, rifampin, vancomycin, or clarithromycin plus one protein (exotoxin) synthesis inhibitor agent; or linezolid, clindamycin, chloramphenicol intravenously for ≥2 weeks (same in pregnant women)."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
"Together with antimicrobial agents."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"c"
]
},
"Three subcutaneous doses (0, 2, and 4 weeks) of anthrax vaccine absorbed (AVA) ≤10 days after exposure (same antimicrobials and vaccine in pregnant women)."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"d"
]
},
"If first-line agents are not available or tolerated."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"e"
]
},
"When alternative preventive therapies are not available or are not appropriate."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"f"
]
},
"Gentamicin is not FDA approved for treatment of plague. Streptomycin may not be readily available. Dual therapy with two distinct classes of antimicrobials should be used for initial treatment of patients with severe pneumonic or septicemic plague and patients infected after intentional release of ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Yersinia pestis"
]
},
"."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"g"
]
},
"Available from the CDC through local State Health Departments."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"h"
]
},
"For suspected or proven meningitis for 14-21 days."
]
]
}
}
}